Search

everythinglearnresearchcommunity

for

Search:↓

The cerium-polypeptide hydrogel effectively heals drug-resistant bacterial wounds by fighting bacteria, reducing inflammation, and promoting tissue repair.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Candida antigen is an effective and promising treatment for alopecia areata.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

EPI-NCSCs from hair follicles may help treat brain development issues in mice.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.